Dr Peters is an Associate Professor in the Faculty of Medicine at the University of New South Wales (Australia), the Program Lead for Dementia at the George Institute for Global Health and holds an honorary appointment at Imperial.
Associate Professor Peters completed her PhD and NIHR Post-doctoral Fellowship at Imperial before relocating to Australia in 2018. Dr Peters’ research combines clinical trials, evidence synthesis, and epidemiology to understand and treat risk factors for dementia and frailty. Her work has influenced WHO and national and international clinical practice guidelines, is used by health advocacy bodies and is regularly featured in the media, for example; https://www.abc.net.au/news/2022-10-26/study-finds-evidence-lowering-blood-pressure-later-can-help/101578342.
A/Prof Peters has been awarded >$10 million (AUD) in research funding, is widely cited and is regularly invited to give talks at conferences and scientific meetings. She has a particular passion for the two areas that show the most potential for helping healthy brain ageing, multidomain risk reduction and the treatment of hypertension.
In multidomain risk reduction, A/Prof Peters is leading the first large multisite trial to test intergenerational practice, a novel multi-domain intervention bringing older adults and preschool children together combining physical activity, cognitive and social engagement to reduce cognitive decline and frailty and co-designed with community members.
In hypertension Dr Peters is currently leading an exciting new research stream at The George Institute for Global Health including innovative clinical trial and evidence synthesis projects in blood pressure lowering, dementia and frailty and has an established international reputation since her early PhD work as cognitive function lead for the award-winning multinational Hypertension in the Very Elderly Trial (HYVET, HYVET -COG).
et al., 2023, Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis., Jama, Vol:330, Pages:1459-1471
et al., 2023, Use of Antihypertensives, Blood Pressure, and Estimated Risk of Dementia in Late Life An Individual Participant Data Meta-Analysis, Jama Network Open, Vol:6, ISSN:2574-3805
et al., 2023, Validation of the CogDrisk Instrument as Predictive of Dementia in Four General Community-Dwelling Populations, Jpad-journal of Prevention of Alzheimers Disease, Vol:10, ISSN:2274-5807, Pages:478-487
et al., 2023, Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk, Bmj Open, Vol:13, ISSN:2044-6055
et al., 2023, CogDrisk, ANU-ADRI, CAIDE, and LIBRA Risk Scores for Estimating Dementia Risk, Jama Network Open, Vol:6, ISSN:2574-3805